Roofing

At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type 8 (TRPM8),...

An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from...

Moreover, it is not completely understood whether these effects are related to CBD or to other organic compounds...

sativa and a CB1 and CB2 receptor partial agonist.PDF] Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid...

Despite the consensus among researchers on the potential of CBD as a neuroprotective agent, larger and well-designed randomized clinical trials will be necessary to gather...

An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400...

Despite the consensus among researchers on the potential of CBD as a neuroprotective agent, larger and well-designed randomized clinical...

An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian...

Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the FAAH enzyme, which catalyzes AEA hydrolysis.Pharmacokinetics, Safety,...

Despite the consensus among researchers on the potential of CBD as a neuroprotective agent, larger and well-designed randomized...